← Leaderboards
Kyle Russell Bonneau
Cellecta, Inc.
$2,096,929
Attributed
$2,096,929
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $941.9K · FY2009–12$1M$750K$500K$250K$0
'09
'10
'11
'12
Funding mix
By agency
NIH$2,096,929 · 2
By mechanism
R44$1,847,464 · 1
R43$249,465 · 1
Top collaborators
No co-investigators on record.
Most similar at Cellecta, Inc.
Same institution · by research overlap
- Andrey Komarov$1,071,536
- Alexandr Chenchik$1,199,277
Others in their field
Top investigators on “Drug Development”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$409,188,846
- Lawrence Corey · Fred Hutchinson Cancer Center$302,964,844
- Wafaa M. El-Sadr · Columbia University Health Sciences$291,216,450
- Constance Ann Benson · University Of California, San Diego$284,817,600
Research focus
Drug DevelopmentGenome-WideConditioningDrug Delivery SystemsGenesGenetic ScreeningCellsCell LineageChemotherapyDatabasesCollaborationsGenerationsGene TargetingBloodBlood CellsCell Body (Neuron)Bar CodesCell LineBaseCell TypeCytotoxicCancer TherapyBioinformaticsHematopoietic
Grant awards (3)
Exploiting synthetic lethality of hematopoietic lineage cells to develop novel ta$905,570
R44 · FY2012 · CA · contact PI
Exploiting synthetic lethality of hematopoietic lineage cells to develop novel ta$941,894
R44 · FY2011 · CA · contact PI
Identification of Hematopoietic Stem and Progenitor Cell Viability Genes$249,465
R43 · FY2009 · CA · contact PI